{"title": "How metabolites target brain-homing immune cells to treat multiple sclerosis", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/immune_system.xml", "value": "How metabolites target brain-homing immune cells to treat multiple sclerosis"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/02/190228093601.htm"}], "link": "https://www.sciencedaily.com/releases/2019/02/190228093601.htm", "summary": "A new study details how metabolites can be used to inhibit epigenetic mechanisms and effectively treat multiple sclerosis and a range of other diseases.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/immune_system.xml", "value": "A new study details how metabolites can be used to inhibit epigenetic mechanisms and effectively treat multiple sclerosis and a range of other diseases."}, "published": "Thu, 28 Feb 2019 09:36:01 EST", "published_parsed": [2019, 2, 28, 14, 36, 1, 3, 59, 0], "id": "https://www.sciencedaily.com/releases/2019/02/190228093601.htm", "guidislink": false}